Scientists at Scripps Research have developed a urine diagnostic to detect the parasitic worms that cause river blindness, also called onchocerciasis, a tropical disease that afflicts 18 to 120 million people worldwide.
Described in the journal ACS Infectious Diseases, the new, non-invasive test may provide an inexpensive method of determining in real time whether a person has an infection, which would give public health officials and doctors critical information for tracking outbreaks and treating current infections.
“River blindness affects individuals both in Africa and Latin America, and because many of these endemic regions are difficult to access, what is needed in the field is an inexpensive point-of-care means to monitor the disease,” says Kim Janda, PhD, the Ely R. Callaway Jr. Professor of Chemistry and member of the Skaggs Institute for Chemical Biology at Scripps Research.
River blindness is a filarial disease, like elephantiasis, and occurs when the parasitic worm Onchocerca volvulus takes up residence in the skin. Adult worms pump out babies (microfilaria) at an alarming rate, which are ultimately re-spread by blackfly bites. The microfilariae can migrate to the eye and die, releasing toxins and causing inflammation. People with the disease will slowly go blind without medical intervention.
Janda says onchocerciasis monitoring and evaluation are especially necessary steps for people leading elimination efforts. To know if these efforts are working, doctors need to be able to show when disease transmission has been interrupted. The current gold standard for detecting the parasitic worms is a “skin snip” biopsy. However, snips are generally insensitive indicators of infection, and the sensitivity of the skin snip decreases as the density of microfilaria in the skin decreases. Other tests cannot distinguish between past and current infections.
Currently, onchocerciasis elimination programs rely primarily on mass drug administration of the therapy Ivermectin to suppress and eventually eliminate transmission of Onchocerca volvulus. Yet, without a means to evaluate if an infection is ongoing, it’s hard to assess if prevention efforts are working—and if it’s safe for people to stop taking medication.
The new lateral flow assay took over 10 years to develop, but it is now ready for manufacturing and testing in the field. The key to the assay’s success was in the making of designer antibodies to detect a unique biomarker that only shows up when a human host has metabolized a worm neurotransmitter called tyramine. Humans then secrete this biomarker in urine.
A negative on the “dipstick” test shows a colored line in the test. Got the parasite? The test would show no lines.
Unlike the skin snip biopsy, Janda says this non-invasive test is the first to use a metabolite produced by adult worms. Moreover, the dipstick’s inexpensive design, coupled with smartphone apps, would offer automatic image processing, which ultimately could translate to address critical gaps in the surveillance and treatment of river blindness.
The Latest on: River blindness
via Google News
The Latest on: River blindness
- Wash U Researchers Awarded $24 Million In Effort To Eradicate Tropical Diseases on April 12, 2019 at 4:45 pm
Elephantiasis and river blindness are parasitic diseases straight out of a horror movie. In both cases, insects bite humans and transmit tiny parasitic worms — which cause debilitating illnesses. ... […]
- Up to $24 million will help to eliminate two tropical diseases on April 11, 2019 at 9:19 am
A large grant will fund clinical trials and other studies aimed at preventing new cases of elephantiasis and river blindness. (Photo: Matt Miller/Washington University School of Medicine) Research ... […]
- AI-based software for detecting river blindness on April 9, 2019 at 11:28 am
Health-tech company Niramai Tuesday said it will develop an artificial intelligence-based software for curbing spread of river blindness, a parasitic disease affecting the skin and eyes. Niramai will ... […]
- Niramai to develop AI-based software for detecting river blindness on April 9, 2019 at 5:39 am
New Delhi, Apr 9 () Health-tech company Niramai Tuesday said it will develop an artificial intelligence-based software for curbing spread of river blindness, a parasitic disease affecting the skin ... […]
- Health tech startup Niramai secures support from Bill & Melinda Gates Foundation on April 9, 2019 at 1:09 am
CHENNAI: AI-based health tech startup Niramai is extending the use of its proprietary breast cancer screening tech Thermalytix to control the spread of the River Blindness disease. Supported by ... […]
- NIRAMAI to Develop Artificial Intelligence-based Software to Detect River Blindness on April 8, 2019 at 11:59 pm
Artificial intelligence-based Indian health-tech company Niramai is currently using Thermalytix to detect breast cancer in the early stages Artificial intelligence-based Indian health-tech company ... […]
- WHO: Determining To Achieve Universal Health Coverage For Africa Through Strategic Partnerships on April 6, 2019 at 12:56 am
In recent years, recent outbreak of diseases like Ebola in Liberia and Republic of Congo claimed no few lives, Laser fever and Yellow fever did not spare Nigeria and few other African countries while ... […]
- Africa: Tackling River Blindness in a Country Ravaged By Ebola on March 25, 2019 at 1:35 am
There were lots of people suffering, needing help, but there was also fear. People were slow to trust. Lincoln Gankpala is health lab technician at the Liberian Ministry of Health. He is currently ... […]
- Tackling river blindness in a country ravaged by Ebola on March 22, 2019 at 10:03 am
Sia Tamba and her children in River Cess region, Liberia, are seen in this undated photo supplied by John Healey/Sightsavers. Global taskforce tackles cybersex child trafficking in the Philippines ... […]
- A possible cure for river blindness and elephantiasis on March 15, 2019 at 6:06 am
An international team of researchers has found what might be a cure for river blindness and elephantiasis. In their paper published in the journal Science Translational Medicine, the group describes ... […]
via Bing News